Short Interest in Sysmex Co. (OTCMKTS:SSMXY) Increases By 900.0%

Sysmex Co. (OTCMKTS:SSMXY - Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 10,000 shares, a growth of 900.0% from the March 15th total of 1,000 shares. Approximately 0.0% of the company's stock are short sold. Based on an average daily volume of 100,300 shares, the days-to-cover ratio is currently 0.1 days.

Sysmex Stock Down 0.6 %

Sysmex stock traded down $0.12 during trading hours on Friday, reaching $18.87. The stock had a trading volume of 35,883 shares, compared to its average volume of 71,767. Sysmex has a 52 week low of $14.38 and a 52 week high of $22.00. The company has a market cap of $11.88 billion, a price-to-earnings ratio of 36.87 and a beta of 1.08. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.19 and a quick ratio of 2.42. The business's 50 day moving average price is $18.49 and its 200-day moving average price is $18.97.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The company reported $0.17 earnings per share (EPS) for the quarter. Sell-side analysts anticipate that Sysmex will post 0.57 EPS for the current year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.